sequences. Fluorescence and CD spectroscopy also demon-
strate that the molecule has a lower affinity for and different
effects on the structure of duplex DNA.
The biological potential of a molecule that promotes the
formation of the HJ is not known. Compound 1 is one of the
few 9-aminoacridine-3-carboxamide structures that we have
studied that has potent antitumour activity (9.1 mM in human
leukaemia HL60 cell line) although the modest difference in
affinity for the HJ versus duplex DNA may suggest that this
derives from classical topoisomerase inhibition rather than
effects on DNA repair processes. However, studies on the
ability of 1 and analogs to target other HJ forming sequences
and their effects on enzymes binding to four way junctions are
underway.
This research also highlights the potential of compounds
that can promote the formation of higher order DNA structures
in nanotechnology. It is likely that screening for compounds
with this ability will allow the formation of DNA nanostructures
without the requirement for a high temperature annealing step
and may change the physicochemical properties of the resulting
structures.
Fig. 4 Gels and densiometry plots showing the percentage of HJ
versus single stranded oligonucleotide over the designated time period.
(a) Oligonucleotides b, h, r and x were mixed together at room
temperature in the presence of 2.0 mM MgCl2 and left in the dark
for the specified time (final HJ concentration 1.25 mM). (b) Oligo-
nucleotides b, h, r and x were mixed together in the presence of 1
(50 mM) at room temperature and left in the dark for the specified time
(final HJ concentration 1.25 mM).
We thank Dr Myles Cheeseman of the Henry Wellcome
Laboratories for Biological Chemistry, UEA, for the use of the
CD spectrometer and Dr Nick Watmough of the School of
Biological Sciences, UEA, for the use of the fluorimeter.
LH was funded by a UEA studentship. We thank the Swansea
EPSRC Mass Spectrometry Service for high resolution mass
spectra.
DNA formed from x and its complementary sequence. Titration
of 1 with the double helical ‘‘control’’ resulted in no changes in
ellipticity (see ESIw), indicating the changes observed in the HJ
samples are the result of a specific interaction with the junction
as opposed to duplex intercalation. This is also consistent with
the 1 : 1 binding mode indicated by the stoichiometry plot.
Finally, we investigated the ability of the ligand to induce
the formation of a HJ without prior annealing using a gel
assay. Mixing the four oligonucleotides in solution at 20 1C in
the presence of 2 mM Mg2+ led to the formation of around
60% HJ over a 24 h period (Fig. 4a), demonstrating that even
in the presence of high concentrations of divalent metal ions, a
high temperature annealing step is required for the formation
of the HJ. Notably, after 6 h, around 40% of the four
way junction is present in solution. Carrying out the same
experiment with 50 mM of compound 1 in both the absence
and presence of Mg2+ ions (2 mM) led to the rapid formation
of the HJ structure even at 20 1C (Fig. 4b shows the experiment in
the presence of the divalent ions). Within 4 h all of the
oligonucleotides in solution had formed the four way junction.
The ability of a small molecule to promote the formation of
a four-way DNA junction is unprecedented. Within higher
order DNA studies, several groups have previously described
molecules that appear to promote the formation of a
G-quadruplex structure, although usually within a defined
intramolecular oligonucleotide sequence.13 Here, compound
1 is not just perturbing the equilibrium between the single strands
and open-X form of the junction but, from the CD data, is
promoting the formation of the X stacked form in a similar
way to divalent metal ions. This suggests that the compound is
promoting the intermolecular assembly of oligonucleotide
Notes and references
1 D. Sun, B. Thompson, B. E. Cathers, M. Salazar, S. M. Kerwin,
J. O. Trent, T. C. Jenkins, S. Neidle and L. H. Hurley, J. Med.
Chem., 1997, 40, 2113.
2 J. L. Huppert and S. Balasubramanian, Nucleic Acids Res., 2007,
35, 406.
3 A. Siddiqui-Jain, C. L. Grand, D. J. Bearss and L. H. Hurley, Proc.
Natl. Acad. Sci. U. S. A., 2002, 99, 11593; S. Rankin, A. P. Reszka,
J. Huppert, M. Zloh, G. N. Parkinson, A. K. Todd, S. Ladame,
S. Balasubramanian and S. Neidle, J. Am. Chem. Soc., 2005,
127, 10584.
4 L. A. Howell and M. Searcey, ChemBioChem, 2009, 10, 2139.
5 M. D. Keppler, P. L. James, S. Neidle, T. Brown and K. R. Fox,
Eur. J. Biochem., 2003, 270, 4982.
6 A. C. G. Hotze, N. J. Hodges, R. E. Hayden, C. Sanchez-Cano,
C. Paines, N. Male, M.-K. Tse, C. M. Bunce, J. K. Chapman and
M. J. Hannon, Chem. Biol., 2008, 15, 1258.
7 G. Cassell, M. Klemm, C. Pinilla and A. M. Segall, J. Mol. Biol.,
2000, 299, 1193.
8 A. L. Brogden, N. H. Hopcroft, M. Searcey and C. J. Cardin,
Angew. Chem., Int. Ed., 2007, 46, 3850.
9 L. A. Howell, A. Howman, M. A. O’Connell, A. Mueller and
M. Searcey, Bioorg. Med. Chem. Lett., 2009, 19, 5880.
10 Compound 1 was isolated as part of a screen of click chemistry
derived acridines. Very similar structures had no effect on the
oligos at 50 mM concentration (see ESIw).
11 D. M. J. Lilley, Q. Rev. Biophys., 2008, 41, 1.
12 T. Shida, H. Iwasaaki, H. Shinagawa and Y. Kyogoku,
J. Biochem., 1996, 119, 653.
13 S. Yang, J. Xiang, Q. Yang, Q. Zhou, X. Zhang, Q. Li, Y. Tang
and G. Xu, Fitoterapia, 2010, 81, 1026.
c
8264 Chem. Commun., 2011, 47, 8262–8264
This journal is The Royal Society of Chemistry 2011